TREAT-NMD ALLIANCE LTD
Financial health, per its FY2024 accounts
The accounts state that the group reported a net movement in funds of £(39,364) for the year, resulting in total unrestricted reserves of £837,146. The trustees confirm that the group has adequate resources to continue in operational existence for the foreseeable future, with no material uncertainties identified regarding going concern. The charity's own reserves policy is described as building levels to support objectives, with current reserves standing at £9,643 for the parent charity.
What the accounts disclose
“The reserves policy for TREAT-NMD Alliance Limited continues to be building levels to support the charity’s objectives.” — page 7
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
“During the year honorarium payments totalling £734 (2023: £1,500) were paid to J Dowling, trustee, for attendance at TACT meetings.” — page 33
“During the year, payments of £27,232 (2023: £18,666) were paid to Muscular Dystrophy Association USA, a charity in which S Hesterlee has signifcant influence, in relation to a gene therapy masterclass.” — page 33
Structured financials (annual return, FY ending 31/07/2024)
Trustees
- Dr Kathryn Wagnerchair
- Prof and Dean Kanneboyina Nagaraju
- Robert von Rosen
- Volker Wilhelm Straub
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2024 | £2.5m | £2.5m |
| 31/07/2023 | £2.2m | £1.9m |
Common questions
Is TREAT-NMD ALLIANCE LTD financially healthy?
The accounts state that the group reported a net movement in funds of £(39,364) for the year, resulting in total unrestricted reserves of £837,146. The trustees confirm that the group has adequate resources to continue in operational existence for the foreseeable future, with no material uncertainties identified regarding going concern. The charity's own reserves policy is described as building levels to support objectives, with current reserves standing at £9,643 for the parent charity. Its FY2024 accounts were audited by UNW LLP.